tradingkey.logo

BRIEF-AstraZeneca CEO Says Company Has No Access To Executive Wang, In Detention In China - Media Call

ReutersFeb 6, 2025 10:15 AM

- AstraZeneca AZN.L Media Call:

  • ASTRAZENECA CEO: CO EXPECTS HEADWINDS FROM VBP INCLUSION OF SEVERAL MEDICINES TO IMPACT GROWTH RATE OF 2025 REVENUES IN CHINA

  • ASTRAZENECA CEO: CO COULD NOT MAKE THE SPEKE, UK, FACILITY INVESTMENT "ECONOMICALLY VIABLE"

  • ASTRAZENECA CEO: ASSESSING ALTERNATIVE SITES FOR MAKING VACCINES THAT WOULD HAVE BEEN MADE AT SPEKE

  • ASTRAZENECA CEO: CHINA TARIFFS WILL NOT AFFECT OUR U.S. BUSINESS BECAUSE WE IMPORT NOTHING FROM CHINA TO U.S.

  • ASTRAZENECA CEO: IT'S POSSIBLE ILLEGAL IMPORTATION PROBE IN CHINA COULD EXTEND TO INCLUDE ENHERTU

  • ASTRAZENECA CEO: UK NEEDS TO CONTINUE IMPROVING THE LIFE SCIENCES INVESTMENT ENVIRONMENT

  • ASTRAZENECA CEO: INCREASED VBAC REBATES IN UK, INCREASING TAXES ON INDUSTRY, IS NOT ENCOURAGING

  • ASTRAZENECA CEO: CO APPROACHED A COUPLE OF TIMES BY CHINESE AUTHORITIES ABOUT WANG INVESTIGATION, AND CO PROVIDED INFORMATION AS NEEDED

  • ASTRAZENCA CEO: HAVE NOT RECEIVED NEW INFORMATION ABOUT DETAINED FORMER EXECUTIVE LEON WANG FROM CHINESE AUTHORITIES

  • ASTRAZENECA CEO: DON'T HAVE INFORMATION TO SHARE ON WANG, ARE NOT PERMITTED TO TALK TO HIM

  • ASTRAZENECA EXECUTIVE: WE WILL INTERACT WITH RFK JR ONCE CONFIRMED TO SHOW HIM BENEFITS OF OUR VACCINES

  • ASTRAZENECA CEO: WILL WORK WITH U.S. FDA AND HHS TO SUPPORT LIFE SCIENCES SECTOR IN U.S.

Further company coverage: AZN.L

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI